Skip to main content
VCbacked
Log inGet Started

NervGen Pharma

Vancouver, Canada

NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.

$60.0M raised
May 2026
Post-IPO Equity
BiotechnologyMedicalPharmaceutical

Top Investors

U.S. Department of DefenseCSBioSCI VenturesPFP BiosciencesPaul and Phyllis Fireman Charitable Foundation

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NervGen Pharma

How much funding has NervGen Pharma raised?
NervGen Pharma has raised $60.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.
Who are NervGen Pharma's investors?
NervGen Pharma's investors include U.S. Department of Defense, CSBio, SCI Ventures, PFP Biosciences, Paul and Phyllis Fireman Charitable Foundation.
Where is NervGen Pharma headquartered?
NervGen Pharma is headquartered in Vancouver, Canada.
What does NervGen Pharma do?
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.
What stage is NervGen Pharma at?
NervGen Pharma is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"NervGen Pharma — Funding & Investors." VCBacked, May 21, 2026, https://www.vcbacked.co/company/nervgen-pharma. Accessed July 2, 2026.
APA
VCBacked. (2026). NervGen Pharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nervgen-pharma
Wikipedia (cite web)
{{cite web |title=NervGen Pharma — Funding & Investors |url=https://www.vcbacked.co/company/nervgen-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K